Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.

Ettrup A, da Cunha-Bang S, McMahon B, Lehel S, Dyssegaard A, Skibsted AW, Jørgensen LM, Hansen M, Baandrup AO, Bache S, Svarer C, Kristensen JL, Gillings N, Madsen J, Knudsen GM.

J Cereb Blood Flow Metab. 2014 Jul;34(7):1188-96. doi: 10.1038/jcbfm.2014.68. Epub 2014 Apr 30.

2.

Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.

Finnema SJ, Stepanov V, Ettrup A, Nakao R, Amini N, Svedberg M, Lehmann C, Hansen M, Knudsen GM, Halldin C.

Neuroimage. 2014 Jan 1;84:342-53. doi: 10.1016/j.neuroimage.2013.08.035. Epub 2013 Aug 28.

PMID:
23994452
3.

Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.

Ettrup A, Svarer C, McMahon B, da Cunha-Bang S, Lehel S, Møller K, Dyssegaard A, Ganz M, Beliveau V, Jørgensen LM, Gillings N, Knudsen GM.

Neuroimage. 2016 Apr 15;130:167-74. doi: 10.1016/j.neuroimage.2016.02.001. Epub 2016 Feb 11.

PMID:
26876490
4.

Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.

Ettrup A, Hansen M, Santini MA, Paine J, Gillings N, Palner M, Lehel S, Herth MM, Madsen J, Kristensen J, Begtrup M, Knudsen GM.

Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):681-93. doi: 10.1007/s00259-010-1686-8. Epub 2010 Dec 21.

PMID:
21174090
5.

Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.

Ettrup A, Holm S, Hansen M, Wasim M, Santini MA, Palner M, Madsen J, Svarer C, Kristensen JL, Knudsen GM.

Mol Imaging Biol. 2013 Aug;15(4):376-83. doi: 10.1007/s11307-012-0609-4.

PMID:
23306971
6.

Cerebral 5-HT release correlates with [11C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain.

Jørgensen LM, Weikop P, Villadsen J, Visnapuu T, Ettrup A, Hansen HD, Baandrup AO, Andersen FL, Bjarkam CR, Thomsen C, Jespersen B, Knudsen GM.

J Cereb Blood Flow Metab. 2017 Feb;37(2):425-434. doi: 10.1177/0271678X16629483. Epub 2016 Jul 20.

PMID:
26825776
7.

Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.

Ettrup A, Palner M, Gillings N, Santini MA, Hansen M, Kornum BR, Rasmussen LK, Någren K, Madsen J, Begtrup M, Knudsen GM.

J Nucl Med. 2010 Nov;51(11):1763-70. doi: 10.2967/jnumed.109.074021. Epub 2010 Oct 18.

8.

Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.

Hansen HD, Herth MM, Ettrup A, Andersen VL, Lehel S, Dyssegaard A, Kristensen JL, Knudsen GM.

J Nucl Med. 2014 Apr;55(4):640-6. doi: 10.2967/jnumed.113.128983. Epub 2014 Feb 24.

9.

Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.

Erritzoe D, Rasmussen H, Kristiansen KT, Frokjaer VG, Haugbol S, Pinborg L, Baaré W, Svarer C, Madsen J, Lublin H, Knudsen GM, Glenthoj BY.

Neuropsychopharmacology. 2008 Sep;33(10):2435-41. doi: 10.1038/sj.npp.1301656. Epub 2008 Feb 20.

10.

Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.

Talbot PS, Slifstein M, Hwang DR, Huang Y, Scher E, Abi-Dargham A, Laruelle M.

Neuroimage. 2012 Jan 2;59(1):271-85. doi: 10.1016/j.neuroimage.2011.07.001. Epub 2011 Jul 18.

11.

A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.

Erritzoe D, Holst K, Frokjaer VG, Licht CL, Kalbitzer J, Nielsen FA, Svarer C, Madsen J, Knudsen G.

J Neurosci. 2010 Mar 3;30(9):3391-7. doi: 10.1523/JNEUROSCI.2852-09.2010.

12.

Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.

Hinz R, Bhagwagar Z, Cowen PJ, Cunningham VJ, Grasby PM.

J Cereb Blood Flow Metab. 2007 Jan;27(1):161-72. Epub 2006 May 10.

PMID:
16685260
13.

Synthesis and evaluation of [¹¹C]Cimbi-806 as a potential PET ligand for 5-HT₇ receptor imaging.

Herth MM, Hansen HD, Ettrup A, Dyssegaard A, Lehel S, Kristensen J, Knudsen GM.

Bioorg Med Chem. 2012 Jul 15;20(14):4574-81. doi: 10.1016/j.bmc.2012.05.005. Epub 2012 May 18.

PMID:
22682922
14.

Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.

Urban NB, Girgis RR, Talbot PS, Kegeles LS, Xu X, Frankle WG, Hart CL, Slifstein M, Abi-Dargham A, Laruelle M.

Neuropsychopharmacology. 2012 May;37(6):1465-73. doi: 10.1038/npp.2011.332. Epub 2012 Feb 22.

15.

(11)C-labeling and preliminary evaluation of pimavanserin as a 5-HT2A receptor PET-radioligand.

Andersen VL, Hansen HD, Herth MM, Dyssegaard A, Knudsen GM, Kristensen JL.

Bioorg Med Chem Lett. 2015 Mar 1;25(5):1053-6. doi: 10.1016/j.bmcl.2015.01.017. Epub 2015 Jan 20.

PMID:
25655720
16.

In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.

Perani D, Garibotto V, Gorini A, Moresco RM, Henin M, Panzacchi A, Matarrese M, Carpinelli A, Bellodi L, Fazio F.

Neuroimage. 2008 Aug 1;42(1):306-14. doi: 10.1016/j.neuroimage.2008.04.233. Epub 2008 Apr 27.

PMID:
18511303
17.

Similar serotonin-2A receptor binding in rats with different coping styles or levels of aggression.

Visser AK, Ettrup A, Klein AB, van Waarde A, Bosker FJ, Meerlo P, Knudsen GM, de Boer SF.

Synapse. 2015 Apr;69(4):226-32. doi: 10.1002/syn.21810. Epub 2015 Feb 28.

PMID:
25684736
18.

Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.

Meyer PT, Bhagwagar Z, Cowen PJ, Cunningham VJ, Grasby PM, Hinz R.

Neuroimage. 2010 Apr 15;50(3):984-93. doi: 10.1016/j.neuroimage.2010.01.037. Epub 2010 Jan 18.

PMID:
20083209
19.

Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2 and serotonin 5-HT (2A) receptor occupancy as measured by positron emission tomography (PET).

Hodé Y, Benyamina A, Arbus C, Reimold M.

Psychopharmacology (Berl). 2011 Oct;217(3):315-21. doi: 10.1007/s00213-011-2289-1. Epub 2011 Apr 9.

PMID:
21479533
20.

Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.

Herth MM, Petersen IN, Hansen HD, Hansen M, Ettrup A, Jensen AA, Lehel S, Dyssegaard A, Gillings N, Knudsen GM, Kristensen JL.

Nucl Med Biol. 2016 Aug;43(8):455-62. doi: 10.1016/j.nucmedbio.2016.02.011. Epub 2016 Apr 19.

PMID:
27209485

Supplemental Content

Support Center